Consumer safety notice Home Investors Hikma at a glance Quickfinder Investors Hikma at a glance Hikma's strategy Acquisitions Our management News Share price Results Centre Financial results Reports Presentations Calendar Shareholder services Corporate governance Analysts Acquisitions Analyst & Investor Day Investor contacts Keep yourself updated about Hikma Stay informed View detailed share price Hikma at a glance Our vision is to build Hikma into a world class, leading specialty pharmaceutical company. This will be achieved through both organic and by acquisitions that align with our strategy. As we build the business, it is our goal to maintain the high standards of ethics and responsibility that have always been central to the way we operate. Quick facts: Our broad geographic footprint spans over 50 countries We are the largest regional pharmaceutical company in MENA 55.4% of our sales are generated in the MENA region We are the licensing partner of choice in the MENA region Our global injectables business serves doctors and hospitals across the US, Europe and MENA. We are leveraging our FDA approved facilities in the MENA region, producing products for sale in the US market Our strategy We have set out six core priorities to achieve our vision Our management Find out more about our senior management team Acquisitions Recent acquisitions have expanded our product portfolio and widened our geographic presence Contact us Stay informed Site map Terms and conditions Disclaimer Privacy policy Cookies policy © Hikma Pharmaceuticals PLC 2014